JPMorgan Chase & Co’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.09M | Buy |
1,696,071
+1,660,039
| +4,607% | +$8.9M | ﹤0.01% | 2289 |
|
|
2025
Q1 | $192K | Sell |
36,032
-18,632
| -34% | -$99.5K | ﹤0.01% | 4455 |
|
|
2024
Q4 | $489K | Buy |
54,664
+15,520
| +40% | +$139K | ﹤0.01% | 4164 |
|
|
2024
Q3 | $431K | Buy |
39,144
+19,735
| +102% | +$217K | ﹤0.01% | 4098 |
|
|
2024
Q2 | $177K | Sell |
19,409
-69
| -0.4% | -$628 | ﹤0.01% | 4327 |
|
|
2024
Q1 | $274K | Sell |
19,478
-2,404
| -11% | -$33.8K | ﹤0.01% | 4290 |
|
|
2023
Q4 | $168K | Buy |
21,882
+4,545
| +26% | +$34.9K | ﹤0.01% | 4534 |
|
|
2023
Q3 | $129K | Sell |
17,337
-10,256
| -37% | -$76.5K | ﹤0.01% | 4469 |
|
|
2023
Q2 | $230K | Buy |
+27,593
| New | +$230K | ﹤0.01% | 4203 |
|
|
2022
Q4 | – | Sell |
-299
| Closed | -$3K | – | 5563 |
|
|
2022
Q3 | $3K | Buy |
+299
| New | +$3K | ﹤0.01% | 5264 |
|
|
2021
Q3 | – | Sell |
-3,635
| Closed | -$46K | – | 5511 |
|
|
2021
Q2 | $46K | Buy |
3,635
+2,281
| +168% | +$28.9K | ﹤0.01% | 4962 |
|
|
2021
Q1 | $23K | Sell |
1,354
-139
| -9% | -$2.36K | ﹤0.01% | 4926 |
|
|
2020
Q4 | $19K | Sell |
1,493
-764
| -34% | -$9.72K | ﹤0.01% | 4587 |
|
|
2020
Q3 | $83K | Buy |
2,257
+1,246
| +123% | +$45.8K | ﹤0.01% | 4128 |
|
|
2020
Q2 | $39K | Sell |
1,011
-1,066
| -51% | -$41.1K | ﹤0.01% | 4283 |
|
|
2020
Q1 | $52K | Sell |
2,077
-6,671
| -76% | -$167K | ﹤0.01% | 4124 |
|
|
2019
Q4 | $310K | Buy |
8,748
+3,396
| +63% | +$120K | ﹤0.01% | 3651 |
|
|
2019
Q3 | $173K | Sell |
5,352
-1,882
| -26% | -$60.8K | ﹤0.01% | 3807 |
|
|
2019
Q2 | $339K | Buy |
7,234
+5,517
| +321% | +$259K | ﹤0.01% | 3536 |
|
|
2019
Q1 | $82K | Buy |
+1,717
| New | +$82K | ﹤0.01% | 4068 |
|
|
2018
Q2 | – | Sell |
-24
| Closed | -$3K | – | 4759 |
|
|
2018
Q1 | $3K | Buy |
+24
| New | +$3K | ﹤0.01% | 4592 |
|